Business Context and Reporting Period
This Form 8-K Current Report was filed by Marathon Patent Group, Inc. on April 24, 2017, regarding events occurring on April 18, 2017. The registrant is an emerging growth company incorporated in Nevada. The filing primarily discloses the entry into a material definitive agreement for a registered direct offering of equity securities.
Key Financial Metrics and Transaction Details
The filing details a capital raise transaction rather than periodic financial performance metrics such as revenue or operating margins. Key transaction figures include:
- Shares Sold: 3,800,000 shares of common stock.
- Share Price: $0.70 per share.
- Warrants Issued to Investors: Warrants to purchase 2,280,000 shares at an exercise price of $0.83 per share.
- Placement Agent Fee: $150,733 (5.67% of gross proceeds) paid to Aegis Capital Corp.
- Agent's Warrant: Warrant to purchase 57,000 shares at an exercise price of $0.77 per share.
- Closing Date: April 21, 2017.
The filing text does not provide clear values for the company's total revenue, profit, cash flow, existing debt, or liquidity positions as of the reporting date.
Material Changes
The primary material change is the increase in outstanding equity and potential dilution resulting from the sale of 3,800,000 shares and the issuance of warrants covering 2,337,000 shares (investor and agent combined). The company entered into a Registration Rights Agreement requiring the filing of a Form S-1 to register the resale of shares underlying the warrants within 45 days of the offering.
Outlook, Risks, and Management Commentary
Management commentary is limited to the execution of the offering. The company relied on Section 4(a)(2) of the Securities Act of 1933 for the exemption from registration for the warrants. The filing notes that the summary of terms is subject to the full text of the attached exhibits (Purchase Agreement, Registration Rights Agreement, and Placement Agency Agreement). No specific forward-looking guidance or risk factors beyond standard transaction terms are detailed in the text provided.
Investor Verification Checklist
- Verify the total gross proceeds from the offering (3,800,000 shares x $0.70).
- Review the attached Form of Warrant (Exhibit 4.1) for specific adjustment provisions and exercise terms.
- Confirm the timeline for the Form S-1 registration statement filing required under the Registration Rights Agreement.
- Assess the dilution impact of the 2,337,000 warrants issued to investors and the placement agent.
- Check the press release (Exhibit 99.1) for additional context on the use of proceeds.